The examination of various body fluids and secretions for malignant cells has now become a well recognized procedure in clinical laboratories. The method certainly has its supporters and enthusiasts, who are obviously encouraged by the frequent finding of positive cases. In neoplasia of the lung, however, the published figures of positive results vary from 20.1 % (Bamforth and Osborn, 1958) to 83.2% (Williams, 1961) for sputum, and 21 % (Boucot and Sokoloff, 1955) to 88.8% (Clerf and Herbut, 1950) for bronchial secretions, although higher figures have been recorded where sputum-inducing agents have been employed.
The wide variation in these figures must be explained, at least partially, by the selection of patients and by differences in technique, especially variation in the number of specimens examined. It is undoubtedly satisfying to identify malignant cells, but this often requires a prolonged search and considerable knowledge and experience, especially if diagnosis is based on the recognition of individual cells, and it is worth considering whether or not such detailed examinations are of significant value to either patient or clinician.
The establishment of a reliable test for the early diagnosis of cancer is constantly being sought, and many clinicians hoped that the presence of malignant cells in the sputum might be detected early in the c6urse of carcinoma of the bronchus, thus providing a simple screening test. Although, un- fortunately, this has sometimes led to the examination being allowed to deteriorate into a 'routine' procedure on all patients admitted to hospital, it is still a matter worth investigating.
In this paper we have reviewed patients who have had sputum, bronchial secretions, or pleural fluid examined for malignant cells and in whom a diagnosis has been firmly established, in order to see if such an examination can be regarded as a reliable screening test in the early diagnosis of cancer and to discover the significant value to clinician and patient of the finding of malignant cells in this material.
The patients have been under review for two to seven years.
MATERIAL AND METHODS
We have reviewed 736 patients who were examined for malignant cells in the sputum, bronchial secretions or pleural fluid and in whom a clear diagnosis had been established. These included 223 cases of bronchial carcinoma and 10 cases of secondary carcinoma of the lung. The type of examination carried out on all the patients is shown in Table I . Histological preparations of sputum were made by collecting directly into Schaudinn's fixative, prepared by mixing two parts of saturated mercuric chloride and one part of absolute alcohol immediately before use. The specimen was left in fixative until it was firm enough to be handled with forceps, then wrapped in tissue paper, transferred to a cassette and dehydrated, cleared, and embedded through graded alcohols, benzene, and paraffin wax in the automatic tissue processor. During blocking, the specimen floated to the top of the wax and consequently this top surface was used for cutting. Blocks were well cut down and the sections were taken from the centre of the material. These were routinely stained with haematoxylin and eosin. This method was preferred because of the ease with which the material was handled and because the histological results are directly comparable with those of tissue sections.
During examination of the bronchial tree through the bronchoscope, bronchial secretions were collected into a small trap tube attached to the suction apparatus. The secretions were sucked from the most suspicious area. They were fixed in freshly prepared 279 C. S. Andrews anid T. Rosser Schaudinn's solution, which was sucked into the tube through the suction apparatus. They were transferred to a small bottle, left in fixative overnight. and then transferred to a small, thin-walled test tube in which they were hand-processed through the alcohols and benzene, being centrifuged and decanted between the solutions. Four changes of paraffin wax were used. and the final paraffin was hardened by placing the tube in cold water. The tubes were placed in the refrigerator to contract the wax and broken to release the block.
Pleural fluid for cytological examination was collected into fresh Schaudinn's solution and. depending upon the amount of precipitate. was processed as either sputum or bronchial secretions.
The diagnosis of malignant cells was based on the usual criteria of cell size and shape, and nuclear size. pyknosis. aberration, and mitoses. When malignant cells are found together in clumps. as they usuallv are, the diagnosis is simple and an assessment of the type of growth can often be made with confidence. The recognition of individual malignant cells is. however, a different matter, and cells from areas of squamous metaplasia. especially in the presence of infection such as bronchiectasis. can give rise to considerable difficulties. Cells from regenerating epthelium after bronchoscopy can also lead to confusion. and for this reason sputum was not re-examined until a week had elapsed after bronchoscopy.
At first malignant cells were only reported if the cytological diagnosis was certain, as it was thought that to describe cells as suspicious or doubtful in a case that was already difficult would not help the clinician. However, with the growth of mutual confidence. it was found that there was a place for the reporting of doubtful positives. and this could in many cases be of considerable value to the clinician. especially if a clear understanding existed between the clinician and the pathologist. These suspicious cases have been included among the positive results. It must be admitted that the finding of malignant cells in the sputum of a patient with no evidence of unilateral diseaFe may give rise to an embarrassing clinical problem. In fact the majority of cases in this series had radiological evidence of unilateral disease, but a special attempt was made to study those in whom cytological evidence of malignancy was the first finding to see if the patient obtained any benefit from such an apparently early diagnosis.
RESULTS
FALSE POSITIVES In the 503 cases with no evidence of neoplasia of the lungs, false positives were reported in four (0.8%). One was diagnosed from bronchial secretions, which were examined in 208 of the cases and thus gave a false positive rate of 0.48 %. The error was made in the early days, and a review of the slide shows that it is extremely unlikely that a positive diagnosis would now be made.
The other three false positives were diagnosed from sputum, which was examined in 458 cases.
giving a false positive rate of 0.65 10. The false positive sample rate of sputum was considerably less than 0.65 I`,, as in many cases several samples of sputum were examined.
Examination of the three false positives individually shows that in one case one sputum only out of three was reported positive, and bronchoscopy, bronchial secretions, and biopsy were all negative; lobectomy was performed for bronchiectasis with lung abscess.
In the second case, one sputum out of four was reported positive, and it was described as doubtful. The patient had an enlarged cervical lymph node, which was eventually removed and sho\ved no evidence of malignancy.
In the third case, two sputa were reported as suspicious, and a further four were all negati've. In only 97 cases, therefore, was detailed cytological investigation necessary, and in only 23 (23%) was it of diagnostic value to the clinician. It is of interest that this figure is almost the same as the over-all rate of positives. Table III shows the number of samples of sputum that had to be examined in each of the 47 cases before malignant cells could be identified. Whilst, obviously, the more specimens examined the more likely malignant cells are to be discovered, three to six samples appears to be a reasonable number to examine before accepting a negative result. Berkson and Snider, and in 1961 by Olsen, Froeb, and Palmer. The published figures are only small so far, but Umiker (1961) considers that the artificial induction of sputum has not only increased the accuracy of pulmonary cytology in the diagnosis of bronchial carcinoma but has broadened the scope of its applicability. Also in 1958, Allan, Whittlesey, and Haroutunian used the inhalation of sulphur dioxide to stimulate the production of sputum, and in 1960 Allan, Whittlesey, and Kelley reported a 98-4% positive cell study in 64 cases of carcinoma of the lung without cough. Fontana, Carr, Woolner, and Miller (1962) , in an evaluation of the methods of sputum induction, concluded that the procedure was effective and valuable but that neither method was superior. Obviously, such a potentially valuable new technique in sputum cytology should be carefully investigated since it apparently offers increased accuracy without increasing the burden of work on the laboratory. Swierenga (1963) discusses methods of obtaining material for cytological diagnosis in bronchial carcinoma. He induces sputum by tracheal lavage with saline and water and also describes bronchial curettage, bronchial swabbing, and gland puncture through the carina. We have no experience of these methods and do not think they are widely practised in this country. They obviously have only a limited application.
Every cytologist considers that he uses the best technique. Most rely upon the original Papanicolaou (1954) technique, although there is now a tendency to concentrate on the examination of specially selected areas, particularly bloodstained ones. The technique we use is probably not widely known; we prefer it because it ensures immediate fixation and avoids any distortion of the cells due to drying. The picture produced by staining with haematoxylin and eosin is directly comparable with that of ordinary tissue sections, and, if necessary, an extensive examination of the material can be carried out by serial sectioning. It is interesting that Olsen et al. (1961) also considered the preparation of a similar 'cell-block' to be advantageous. The method is very popular with technicians because of the ease of handling the material, although the actual preparation of the slide takes longer than the smear method. However, at the present time, most cytologists would agree with Russell, Neidhardt, Mountain, Griffith, and Chang (1963) , who conclude that multiple specimens are more important than specific methods and that several areas from each specimen should be examined. These authors also describe a technique of membrane filtration concentration of the sputum based on methods described by Seal (1956) , Haynes (1942), and Farber, Pharr, Wood, and Gorman (1953) . This appears to be an interesting and stimulating new approach to sputum cytology, but unfortunately the published figures for this method do not indicate any great increase in accuracy.
We found it disappointing that in no case did the finding of malignant cells in the sputum provide the first sign of malignant disease in the lung. Even in those patients subjected to prolonged observation before malignancy occurred, the presence of malignant cells was not the first evidence of the disease. The examination of the sputum for malignant cells, by the method adopted, can in no way be considered as a simple satisfactory screening test for carcinoma.
In the majority of cases of bronchial carcinoma the diagnosis was confidently made by the usual clinical methods. Exfoliative cytology has not superseded these, neither does it confer any special benefits; in fact it is not required as a routine procedure and may give rise to considerable waste of time and expenditure in the laboratory. This is perhaps now becoming more generally recognized. As Farber (1961) has pointed out, the years of experience considerably tempered the optimism of the enthusiasts of pulmonary cytology, and, although an accurate cytological technique has been developed, its clinical application has not been as rewarding as was anticipated.
We conclude that exfoliative cytology has failed to alter radically the diagnosis and prognosis of carcinoma of the bronchus as it was hoped it would, and it is simply a useful adjunct to the well tried methods of investigation. We feel that the real value of the search for malignant cells in the sputum lies in the close co-operation between the clinician and the pathologist in the difficult, suspicious case when other methods have failed. When it is decided to examine the sputum for malignant cells, multiple specimens of true earlymorning sputum must be examined. Care should be taken to see that the specimen is in fact sputum and that it has been passed directly into fresh fixative. At least three, and preferably six, specimens should be examined. Even so, only in about 25% of cases can the clinician expect any help from the pathologist. Our figures are remarkably similar to those of Umiker (1961) , who found that in 25 % of cases of bronchial carcinoma the finding of malignant cells in the sputum, bronchial secretions or pleural fluid provided the only definite evidence of a carcinoma before thoracotomy or necropsy. It is in these difficult cases that the development of mutual trust between the clinician and the pathologist is most important, and the reporting of doubtful or abnormal cells suspicious of malignancy may be of great value. Little harni appears to come to patients because of the occasional unfortunate reporting of false positives. It seems likely that with the more readily available thoracic services and the decreasing surgical risk, exploratory thoracotomy will be used more frequently and provide a more realistic approach to the early diagnosis of lung cancer.
In this series it appeared that malignant cells were shed into the sputum by almost a constant proportion (about 25%) of bronchial carcinomata, whichever way the series was analysed. Malignant cells were shed equally by all histological types of bronchial carcinomata, with the exception of adenocarcinoma, and by tumours situated anywhere in the lungs. We must therefore look for some other factor that is responsible for some tumours shedding cells while others do not. It may simply be a matter of tumour breakdown and necrosis: whilst this is difficult to estimate and was not attempted in this series, it would perhaps provide an explanation of why the prognosis in patients with malignant cells seemed to be slightly worse than in those without malignant cells. In this respect it is worth recording that our findings differ from those of Umiker (1961) , who found that hilar tumours and those in the lower lobe most commonly shed malignant cells, but he noted that the larger peripheral tumours of more than 5 cm. diameter shed malignant cells as frequently as the hilar tumours. In his series, apparently the size of the hilar tumours had no bearing on their ability to shed malignant cells.
The finding of malignant cells in bronchial secretions seldom provided more information than bronchoscopy and biopsy. There were positive findings in five (9.6%) of 51 patients in whom bronchoscopy and biopsy were negative. The knowledge that the bronchoscopy or biopsy was positive did not appear to influence unduly the finding of malignant cells in the bronchial secretions; the secretions were positive in 25 (25.5%) of 98 patients from whom secretions were taken and in whom bronchoscopy was considered to give positive evidence of carcinoma; and the secretions were positive in 19 (29%) of 64 patients in whom biopsy was positive. Here again the proportion of tumours giving rise to malignant cells in the secretions appears to be fairly constant, but oat-cell and epidermoid carcinomata more commonly gave rise to malignant cells than other types of tumour. We consider that this was most likely explained by the fact that these tumours are usually situated at the hilum of the lung, and it is not surprising that hilar tumours most commonly give rise to malignant cells in bronchial secretions.
So far as we could judge, exfoliative cytology appeared to have little value in secondary carcinoma of the lung, and this would presumably depend on whether or not the secondary was in connexion with the bronchus.
It seemed to us that patients with malignant cells in either the sputum or the bronchial secretions had a slightly worse prognosis than those without malignant cells, and a greater proportion of operations in the positive group had to be abandoned because of unexpected tumour spread. Although the differences between groups did not actually attain statistical significance, this did suggest to us what is surely a reasonable assumption, namely, that malignant cells are more likely to be shed by tumours that have become well established and have been subject to necrosis and ulceration. This may perhaps be of some help to the surgeon in his assessment of the case.
SUMMARY
Seven hundred and thirty-six patients examined for malignant cells in the sputum, bronchial secretions, or pleural fluid are reviewed. They include 223 cases of bronchial carcinoma and 10 cases of secondary carcinoma of the lung.
False positives were reported in 0.48% of cases in which the bronchial secretions had been examined and in 0.65% of cases in which the sputum had been examined. Positives were reported in 23 % of cases in which the sputum was examined, in 20% of cases in which bronchial secretions were examined, and in 35 % of the cases in which pleural fluid was examined.
Malignant cells in the sputum were shed by all types of tumour equally, with the exception of adenocarcinoma, and by tumours anywhere in the lung; and malignant cells were found in bronchial secretions more commonly from oat-cell and epidermoid carcinomata and tumours situated at the hilum of the lung.
It 
